Related Experiment Video
Updated: Jul 12, 2026

09:03
The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice
Published on: February 3, 2012
Undetectable caeruloplasmin values in a patient with autoimmune chronic active hepatitis
1Department of Medicine A, Hadassah University Hospital, Jerusalem, Israel.
Gut
|May 1, 1991
Summary
Low caeruloplasmin levels can indicate Wilson's disease, but this case shows it can also occur with chronic active hepatitis. Steroid treatment improved both caeruloplasmin levels and the patient's condition.
Area of Science:
- Biochemistry
- Hepatology
- Internal Medicine
Background:
- Caeruloplasmin, an alpha 2 glycoprotein synthesized by the liver, plays a crucial role in copper transport.
- Elevated caeruloplasmin levels are typical in chronic liver diseases like chronic active hepatitis.
- Conversely, significantly low caeruloplasmin concentrations are a hallmark of Wilson's disease.
Observation:
- A case study involving a 17-year-old female patient presented with markedly diminished serum caeruloplasmin levels.
- The patient was simultaneously diagnosed with chronic active hepatitis of the lupoid type.
- This presentation posed a diagnostic challenge, differentiating between Wilson's disease and other hepatic conditions.
Findings:
- The patient exhibited very low caeruloplasmin values, atypical for chronic active hepatitis alone.
- Despite the presence of chronic active hepatitis, the low caeruloplasmin levels initially suggested Wilson's disease.
- Treatment with corticosteroids led to a notable increase in serum caeruloplasmin concentration.
Implications:
- This case highlights that very low caeruloplasmin levels are not exclusive to Wilson's disease and can be observed in certain chronic liver conditions.
- The findings suggest that steroid therapy may positively influence caeruloplasmin levels in patients with autoimmune hepatitis.
- Effective management of the underlying liver disease can potentially restore normal or near-normal caeruloplasmin concentrations.
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Hepatitis
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Cirrhosis I: Introduction
Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...

